
    
      This is a prospective, multicenter clinical trial to assess the efficacy and the safety of
      the STARfloâ„¢ Glaucoma Implant.

      Patients will enter the study after providing written informed consent. Patients will be
      screened to confirm that they are eligible for study participation.

      When eligibility has been established using the in/exclusion criteria, surgery will be
      scheduled.

      Pre and post-surgery, patients will be evaluated at scheduled intervals (1 day, 1 week, 1
      month, 3 months, 6 months, 12 months, 24 months) for a total duration of 24 months following
      surgery.
    
  